Big Take Podcast
Weight-Loss Shots Raise Challenges for Eating Disorder Recovery
On today’s Big Take podcast: Ozempic copycats are getting easier to access. That’s introducing new risks for people recovering from eating disorders.
Eating disorder specialists are seeing an influx of patients who’ve relapsed after getting access to weight-loss shots.
Photographer: Carsten Snejbjerg/BloombergThis article is for subscribers only.
Never miss an episode. Listen and follow The Big Take on Apple Podcasts, Spotify or wherever you get your podcasts.
Drugs like Ozempic and Wegovy have skyrocketed in popularity over the past few years. To capitalize on that demand, telehealth companies started offering compounded versions of those drugs. That’s made them easier to access, but it’s also introduced new potential risks for people recovering from eating disorders like anorexia.